Physician and stakeholder perceptions of conflict of interest policies in oncology

Journal of Clinical Oncology

Volumn 31, Issue 13, 2013, Pages 1677-1682

  Lockhart, A Craig ^a   Brose, Marcia S ^b   Kim, Edward S ^c   Johnson, David H ^f   Peppercorn, Jeffrey M ^d   Michels, Dina L ^g   Storm, Courtney D ^g   Schuchter, Lynn M ^b   Rathmell, W Kimryn ^e  

^a USA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c LEVINE CANCER INSTITUTE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g AMERICAN SOCIETY OF CLINICAL ONCOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER SURVIVOR; CONFLICT MANAGEMENT; CONFLICT OF INTEREST; CONSUMER; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL SOCIETY; ONCOLOGY; ORGANIZATIONAL POLICY; PATIENT ADVOCACY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RESEARCH; ADVISORY COMMITTEE; ETHICS; HEALTH CARE QUALITY; ORGANIZATION AND MANAGEMENT; PHYSICIAN; STANDARD;

ADVISORY COMMITTEES; CONFLICT OF INTEREST; HUMANS; MEDICAL ONCOLOGY; PHYSICIANS; QUALITY OF HEALTH CARE;

EID: 84884546497     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.47.5475     Document Type: Article

References (19)

1. Wilson D: Medical industry ties often undisclosed in journals. New York Times, September 14, 2010:B1
2. Berwick DM, Sebelius K: Transparency reports and reporting of physician ownership or investment interests. Federal Register 76:78767, 2011
3. Wilson D: Harvard teaching hospitals cap outside pay. New York Times, January 3, 2010:A1
4. Rothman DJ, Chimonas S: Academic medical centers’ conflict of interest policies. JAMA 304: 2294-2295, 2010
5. Association of American Medical Colleges: Conflicts of interest in research. https://www.aamc.org/initiatives/coi/
6. Patient Protection and Affordable Care Act of 2009. H.R. 3590, § 6002
7. Als-Nielsen B, Chen W, Gluud C, et al: Association of funding and conclusions in randomized drug trials: A reflection of treatment effect or adverse events? JAMA 290:921-928, 2003
8. Golder S, Loke YK: Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies? Br J Clin Pharmacol 66:767-773, 2008
9. American Society Of Clinical Oncology: Revised conflict of interest policy. J Clin Oncol 24:519-521, 2006
10. Revisions of and clarifications to the ASCO conflict of interest policy. J Clin Oncol 24:517-518, 2006
11. American Society of Clinical Oncology: Revised conflict of interest policy. J Clin Oncol 21: 2394-2396, 2003
12. American Society of Clinical Oncology policy statement: Oversight of clinical research. J Clin Oncol 21:2377-2386, 2003
13. American Society of Clinical Oncology: Background for update of conflict of interest policy. J Clin Oncol 21:2387-2393, 2003
14. Irwin RS: The role of conflict of interest in reporting of scientific information. Chest 136:253-259, 2009
15. Institute of Medicine: Clinical Practice Guidelines We Can Trust. Washington, DC, National Academy of Sciences, 2011
16. Council of Medical Specialty Societies: Code for interactions with companies. http://www.cmss.org/codeforinteractions.aspx
17. AmericanSocietyofClinicalOncology:Leadership Development Program. http://www.asco.org/ASCOv2/Education%26Training/Training/Leadership Training/LeadershipDevelopmentProgram
18. Likert R: A technique for the measurement of attitudes. Archives of Psychology 140:1-55, 1932
19. Patterson WB, Emanuel EJ: Physician-drug company conflict of interest. J Clin Oncol 14:316-320, 1996